Literature DB >> 21167597

Engineered silk fibroin protein 3D matrices for in vitro tumor model.

Sarmistha Talukdar1, Mahitosh Mandal, Dietmar W Hutmacher, Pamela J Russell, Carolina Soekmadji, Subhas C Kundu.   

Abstract

3D in vitro model systems that are able to mimic the in vivo microenvironment are now highly sought after in cancer research. Antheraea mylitta silk fibroin protein matrices were investigated as potential biomaterial for in vitro tumor modeling. We compared the characteristics of MDA-MB-231 cells on A. mylitta, Bombyx mori silk matrices, Matrigel, and tissue culture plates. The attachment and morphology of the MDA-MB-231 cell line on A. mylitta silk matrices was found to be better than on B. mori matrices and comparable to Matrigel and tissue culture plates. The cells grown in all 3D cultures showed more MMP-9 activity, indicating a more invasive potential. In comparison to B. mori fibroin, A. mylitta fibroin not only provided better cell adhesion, but also improved cell viability and proliferation. Yield coefficient of glucose consumed to lactate produced by cells on 3D A. mylitta fibroin was found to be similar to that of cancer cells in vivo. LNCaP prostate cancer cells were also cultured on 3D A. mylitta fibroin and they grew as clumps in long term culture. The results indicate that A. mylitta fibroin scaffold can provide an easily manipulated microenvironment system to investigate individual factors such as growth factors and signaling peptides, as well as evaluation of anticancer drugs. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21167597     DOI: 10.1016/j.biomaterials.2010.11.052

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  30 in total

1.  3D tumour models: novel in vitro approaches to cancer studies.

Authors:  Agata Nyga; Umber Cheema; Marilena Loizidou
Journal:  J Cell Commun Signal       Date:  2011-04-16       Impact factor: 5.782

Review 2.  Silk as an innovative biomaterial for cancer therapy.

Authors:  Katarzyna Jastrzebska; Kamil Kucharczyk; Anna Florczak; Ewelina Dondajewska; Andrzej Mackiewicz; Hanna Dams-Kozlowska
Journal:  Rep Pract Oncol Radiother       Date:  2014-12-18

Review 3.  Biomaterials-Based Approaches to Tumor Spheroid and Organoid Modeling.

Authors:  Pradip Shahi Thakuri; Chun Liu; Gary D Luker; Hossein Tavana
Journal:  Adv Healthc Mater       Date:  2017-12-04       Impact factor: 9.933

4.  3D polylactide-based scaffolds for studying human hepatocarcinoma processes in vitro.

Authors:  Roberto Scaffaro; Giada Lo Re; Salvatrice Rigogliuso; Giulio Ghersi
Journal:  Sci Technol Adv Mater       Date:  2012-07-23       Impact factor: 8.090

5.  Tissue-engineered 3D cancer-in-bone modeling: silk and PUR protocols.

Authors:  Ushashi Dadwal; Carolyne Falank; Heather Fairfield; Sarah Linehan; Clifford J Rosen; David L Kaplan; Julie Sterling; Michaela R Reagan
Journal:  Bonekey Rep       Date:  2016-10-19

6.  Effect of initial cell seeding density on 3D-engineered silk fibroin scaffolds for articular cartilage tissue engineering.

Authors:  Sarmistha Talukdar; Quynhhoa T Nguyen; Albert C Chen; Robert L Sah; Subhas C Kundu
Journal:  Biomaterials       Date:  2011-09-08       Impact factor: 12.479

7.  3d Tissue Engineered In Vitro Models Of Cancer In Bone.

Authors:  Anna M Sitarski; Heather Fairfield; Carolyne Falank; Michaela R Reagan
Journal:  ACS Biomater Sci Eng       Date:  2017-06-09

8.  Bioengineered human tumor within a bone niche.

Authors:  Aranzazu Villasante; Alessandro Marturano-Kruik; Gordana Vunjak-Novakovic
Journal:  Biomaterials       Date:  2014-04-18       Impact factor: 12.479

9.  Impact of silk biomaterial structure on proteolysis.

Authors:  Joseph Brown; Chia-Li Lu; Jeannine Coburn; David L Kaplan
Journal:  Acta Biomater       Date:  2014-09-21       Impact factor: 8.947

10.  The dominant role of IL-8 as an angiogenic driver in a three-dimensional physiological tumor construct for drug testing.

Authors:  Pamela H S Tan; Su Shin Chia; Siew Lok Toh; James C H Goh; Saminathan Suresh Nathan
Journal:  Tissue Eng Part A       Date:  2014-04-30       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.